These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1602293)
21. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. Láinez MJ; Galván J; Heras J; Vila C Eur J Neurol; 2007 Mar; 14(3):269-75. PubMed ID: 17355546 [TBL] [Abstract][Full Text] [Related]
22. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326 [TBL] [Abstract][Full Text] [Related]
23. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
24. Ketoprofen versus paracetamol in the treatment of acute migraine. Karabetsos A; Karachalios G; Bourlinou P; Reppa A; Koutri R; Fotiadou A Headache; 1997 Jan; 37(1):12-4. PubMed ID: 9046717 [TBL] [Abstract][Full Text] [Related]
25. Ergotamine: its use in the treatment of migraine and its complications. Saxena VK; De Deyn PP Acta Neurol (Napoli); 1992 Apr; 14(2):140-6. PubMed ID: 1329442 [TBL] [Abstract][Full Text] [Related]
26. Systemic availability of ergotamine tartrate after three successive doses and during continuous medication. Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E Eur J Clin Pharmacol; 1979 Nov; 16(5):355-60. PubMed ID: 520404 [No Abstract] [Full Text] [Related]
27. Controlled clinical trial of ergotamine tartrate. Waters WE Br Med J; 1970 May; 2(5705):325-7. PubMed ID: 4913961 [TBL] [Abstract][Full Text] [Related]
28. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M; Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714 [TBL] [Abstract][Full Text] [Related]
29. Fixed drug combinations for the acute treatment of migraine : place in therapy. Loder E CNS Drugs; 2005; 19(9):769-84. PubMed ID: 16142992 [TBL] [Abstract][Full Text] [Related]
31. [Ergotamine addiction in migraine patients]. Retterstol N Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2122. PubMed ID: 4773989 [No Abstract] [Full Text] [Related]
32. Single nightly administration of ketoprofen (Orudis) and indomethacin suppositories in the management of osteoarthritis: a double-blind trial. Fava G; Galli L; Pollini C; Liverta C; Vicari A; Pontiroli AE J Int Med Res; 1977; 5(5):301-7. PubMed ID: 334604 [TBL] [Abstract][Full Text] [Related]
33. [The comparison of sodium valproate and ergotamine titrate plus caffeine in the abortive treatment of migraine attacks]. Kozubski W; Prusiński A Neurol Neurochir Pol; 1995; 29(6):929-35. PubMed ID: 8714730 [TBL] [Abstract][Full Text] [Related]
34. Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo. Friedman AP; Di Serio FJ; Hwang DS Clin Ther; 1989; 11(1):170-82. PubMed ID: 2497984 [TBL] [Abstract][Full Text] [Related]
35. Dosing and administration of ergotamine tartrate and dihydroergotamine. Mathew NT Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471 [TBL] [Abstract][Full Text] [Related]
37. Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache. Ryan RE Headache; 1970 Jan; 9(4):212-20. PubMed ID: 4904954 [No Abstract] [Full Text] [Related]
38. Reduction in the intensity of abortive migraine drug use during coumarin therapy. Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG Headache; 2001 Sep; 41(8):768-73. PubMed ID: 11576200 [TBL] [Abstract][Full Text] [Related]